Khatereh Ahmadi

Head of Search and Evaluation Team, European BD&L Hub at MSD

Speaker

Board member since May 2024. Dr. Khatereh Ahmadi has a PhD in biochemistry from King's College London and held a post-doctoral position at the Ludwig Institute for Cancer Research in London. She also holds an MBA from Henley Management College.

Previous experience: With over 20 years of experience in the pharmaceutical industry, Dr Khatereh Ahmadi currently holds the role of Head of Search and Evaluation Business Development Europe & Middle East at MSD, where she has also been actively involved in business development and licensing in the oncology space in Europe. Prior to joining MSD, she was co-founder and CEO of reViral Ltd, a biotechnology company focused on antiviral therapies. Under her leadership, the company secured a $21 million Series A funding round with investors such as Andera Partners and Orbimed. Dr. Ahmadi also played a critical role in founding the oncology company Piramed Ltd where she became head of business development and negotiated a comprehensive license agreement with Genentech and later acquisition by Roche. Dr. Ahmadi has also been a consultant to a number of companies in the EU and the US in the field of oncology.